IMPORTANT DISCLOSURE REGARDING PAID EXPERTS AND MATERIAL NON-PUBLIC INFORMATION:
JMP has adopted certain policies and procedures to verify that our featured experts can identify “material non-public information” and that they will not divulge any such information during our discussion. Such experts are required, among other things, to certify that they have no other conflict, contractual or otherwise, that would make their presentation contrary to any rule, law or regulation.
The featured speakers have been vetted and approved by JMP’s Research and/or Compliance Department for participation in this discussion.
- Dr. Jordan Gauthier is a Clinical Investigator of trials of autologous CD19-targeted CAR T cell therapy.